Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis
JHEP Reports · 2023-08 · 5 (8) · 100788
DOI: 10.1016/j.jhepr.2023.100788 ↗Kurz gefasst
Fachartikel in der Zeitschrift JHEP Reports, 2023-08. Verfasst von Nipun Verma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background & Aims: The reported burden of multidrug-resistant organism (MDRO) infections is highest in patients with cirrhosis from India. We evaluated whether colonisation at multiple barriers predisposes to such infections and poor outcomes in patients with cirrhosis.
Methods
We prospectively performed swab cultures, antimicrobial susceptibility testing (AST), and genotype testing for MDROs from various sites (rectum, nose, composite-skin, and central-line) in patients with cirrhosis (2020-2021) on admission and follow-up at a tertiary institute. We analysed clinical data, risk factors for MDROs, and patient outcomes.
Results
Of 125 patients aged 49 years, 85.6% males, 60.8% with acute-on-chronic liver failure, 99 (79.2%) were identified as 'colonisers'. MDRO-colonisation at rectum, nose, skin, or central line was observed in 72.7% (88/121), 30.0% (36/120), 14.9% (18/121), and 3.3% (4/121) patients, respectively. Patients were colonised with the following types of bacteria: extended-spectrum beta-lactamase (71/125), carbapenem-resistant Enterobacterales (67/125), MDR-Enterococcus (48/125), MDR-Acinetobacter (21/125), or methicillin-resistant Staphylococcus aureus (4/125). Multiple precipitants of acute-decompensation (odds ratio [OR]: 3.4, p = 0.042), norfloxacin prophylaxis (OR: 3.9, p = 0.008), and MDRO infection at admission (OR: 8.9, p = 0.041) were the independent predictors of colonisation. Colonisation increased the risk of infection by MDROs at admission (OR: 8.5, p = 0.017) and follow up (OR: 7.5, p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Zitieren
APA
Verma, N., Divakar Reddy, P. V., Vig, S., Angrup, A., Biswal, M., Valsan, A., Garg, P., Kaur, P., Rathi, S., De, A., Premkumar, M., Taneja, S., Ray, P., Duseja, A., & Singh, V. (2023). Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis. JHEP Reports, 5(8), 100788. https://doi.org/10.1016/j.jhepr.2023.100788
Vancouver
Verma N, Divakar Reddy PV, Vig S, Angrup A, Biswal M, Valsan A, et al. Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis. JHEP Reports. 2023;5(8):100788. doi:10.1016/j.jhepr.2023.100788
BibTeX
@article{Verma2023,
author = {Verma, Nipun and Divakar Reddy, P Venkata and Vig, Shashi and Angrup, Archana and Biswal, Manisha and Valsan, Arun and Garg, Pratibha and Kaur, Parminder and Rathi, Sahaj and De, Arka and Premkumar, Madhumita and Taneja, Sunil and Ray, Pallab and Duseja, Ajay and Singh, Virendra},
title = {Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis},
journal = {JHEP Reports},
year = {2023},
volume = {5},
number = {8},
pages = {100788},
doi = {10.1016/j.jhepr.2023.100788}
}
EUVIMED